cro.directory
← Compare landing

ERGOMED Group vs Ergomed Clinical Research

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryERGOMED GroupErgomed Clinical Research
SummaryGlobal, full-service CRO specializing in oncology and rare disease clinical development, with complementary pharmacovigilance and QA consulting brands.Ergomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.
Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • Oncology Specialty Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Regulatory Affairs
  • US FDA Regulatory Strategy
ModalitiesData not yet provided.
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
Indications
  • Oncology
  • Rare Disease
  • Oncology
  • Rare Disease
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Global Headquarters, Guildford, Surrey, United Kingdom
  • US Headquarters, Raleigh, NC, United States
  • Headquarters, Raleigh, North Carolina, United States
  • Operational Hub, Boston, Massachusetts, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

ERGOMED Group alternatives · Ergomed Clinical Research alternatives

Markdown mirror: /compare/ergomed/medsource.md